je.st
news
Celgene and Juno Announce Ten-Year Collaboration to Advance...
2015-06-29 23:23:19| Biotech - Topix.net
Broad strategic collaboration leveraging combined immunology expertise and assets to develop and commercialize novel immunotherapies for the treatment of cancer and autoimmune diseases Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time SUMMIT, N.J. & SEATTLE-- -- Celgene Corporation and Juno Therapeutics, Inc. announced today a global collaboration for the development and commercialization of immunotherapies.
Tags: advance
collaboration
announce
juno
Category:Biotechnology and Pharmaceuticals